Ligand profile
B62
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03130 — Dihydropteroate synthase type-1
Identifiers
Database identifiers and provenance.
- Ligand ID
B62- PDB
3h2n- UniProt (similar protein)
Q81VW8- Target protein
- KP13_03130
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 95.8
- −1 ≤ LogP ≤ 5 -0.42
- MW ≤ 500 Da 181.2
- LogP ≤ 5 -0.42
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 0
- TPSA ≤ 140 Ų 95.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@@H]1CNC2=C(N1)C(=O)NC(=N2)NC[C@@H]1CNC2=C(N1)C(=O)NC(=N2)N
InChI=1S/C7H11N5O/c1-3-2-9-5-4(10-3)6(13)12-7(8)11-5/h3,10H,2H2,1H3,(H4,8,9,11,12,13)/t3-/m1/s1InChI=1S/C7H11N5O/c1-3-2-9-5-4(10-3)6(13)12-7(8)11-5/h3,10H,2H2,1H3,(H4,8,9,11,12,13)/t3-/m1/s1
HWOZEJJVUCALGB-GSVOUGTGSA-NHWOZEJJVUCALGB-GSVOUGTGSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00809
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand B62 →
- PDB RCSB structure 3h2n →
- UniProt UniProt Q81VW8 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “B62”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03130.
PDB 46
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 26
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).